| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| H0016 |
Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) |
34,014 |
23,728 |
$6.60M |
| H0033 |
Oral medication administration, direct observation |
5,229 |
4,065 |
$776K |
| H0047 |
Alcohol and/or other drug abuse services, not otherwise specified |
2,053 |
1,499 |
$742K |
| 99484 |
|
19,553 |
16,467 |
$471K |
| H0014 |
Alcohol and/or drug services; ambulatory detoxification |
1,922 |
895 |
$434K |
| 80305 |
|
47,887 |
30,621 |
$234K |
| H0049 |
Alcohol and/or drug screening |
11,381 |
6,626 |
$187K |
| G2087 |
Office-based treatment for opioid use disorder, including care coordination, individual therapy and group therapy and counseling; at least 60 minutes in a subsequent calendar month |
5,552 |
4,092 |
$158K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
10,557 |
6,369 |
$154K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
3,131 |
2,406 |
$128K |
| H2010 |
Comprehensive medication services, per 15 minutes |
2,029 |
872 |
$92K |
| 81025 |
|
9,931 |
7,171 |
$34K |
| G2086 |
Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month |
163 |
142 |
$31K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
648 |
486 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,847 |
1,789 |
$12K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
1,187 |
831 |
$9K |
| 99205 |
Prolong outpt/office vis |
133 |
95 |
$8K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
171 |
138 |
$7K |
| 99492 |
|
76 |
69 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
560 |
402 |
$5K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
77 |
67 |
$3K |
| 99406 |
|
705 |
370 |
$2K |
| 99401 |
|
182 |
123 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
618 |
436 |
$820.12 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
498 |
365 |
$591.98 |
| 90832 |
Psychotherapy, 30 minutes with patient |
496 |
373 |
$364.37 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
80 |
68 |
$146.38 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
15 |
13 |
$97.32 |
| 80074 |
|
18 |
12 |
$59.17 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
46 |
25 |
$43.12 |
| 4004F |
|
875 |
485 |
$0.04 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
404 |
245 |
$0.02 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
260 |
208 |
$0.00 |